MeSH D009041 - motion sickness
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Meclizine | Meclizine |  | 1982-01-01 |  |  |
| Perrigo | Ibuprofen, Diphenhydramine | Ibuprofen Diphenhydramine |  | 2008-12-22 |  |  |
| GSK | Ibuprofen, Diphenhydramine | Advil | 2022-01-17 | 2005-12-21 |  |  |
| Cipla | Meclizine | Meclizine |  | 2022-02-17 |  |  |
| Chartwell Pharmaceuticals | Meclizine | Meclizine |  | 2022-08-11 |  |  |
| Sandoz | Meclizine | Meclizine |  | 1989-05-22 |  |  |
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
100%2/2
Phase 3
71%5/7
Approved: 5Overall Success rate: 71%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use